Evonik has signed a purchase agreement to acquire the privately owned technology-driven company Infinitec Activos, boosting its system solutions portfolio.
WHO: Infinitec Activos is a privately owned Spanish technology-driven company founded in 2004 that focuses on the development and production of novel active delivery systems for cosmetic active ingredient applications.
Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €12.2 billion and an operating profit (adjusted EBITDA) of €1.91 billion in 2020 with about 33,000 employees.
WHY: This latest acquisition continues the portfolio shift of Evonik’s life science division Nutrition & Care towards system solutions, which are characterized by high-growth prospects and above-average margin potential. Nutrition & Care aims to increase the share of system solutions it offers from 20 percent today, to more than 50 percent by 2030.
IN THEIR OWN WORDS: “Proven active delivery systems offer great opportunities to innovate new cosmetic ingredients with scientifically proven claims. This allows our personal care customers to differentiate,” said Yann d'Hervé, head of Evonik's Care Solutions business line.
“We are convinced that the synergies created will not only bring benefits to our customers and both companies, but also create new opportunities across the entire personal care and beauty market value chain,” said Alfonso Hidalgo, Partner of Infinitec Activos S.L.
DETAILS: